Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1394187

Cover Image

PUBLISHER: Acute Market Reports | PRODUCT CODE: 1394187

C-reactive Protein Testing Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

PUBLISHED:
PAGES: 113 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 6500
PDF (Enterprise License)
USD 9000

Add to Cart

Description

Table of Contents

List of Tables

The C-reactive protein (CRP) testing market plays a crucial role in diagnosing and monitoring various health conditions, providing valuable insights into inflammation, cardiovascular diseases, autoimmune disorders, and cancer. The C-reactive protein testing market is expected to grow at a CAGR of 0.3% during the forecast period of 2023 and 2031, driven by the rising prevalence of chronic diseases, the adoption of preventive medicine, and continuous advancements in diagnostic technologies. However, regulatory challenges and quality assurance remain significant constraints. With a considerable CAGR projected in the cancer segment and the Asia-Pacific region, the market is set for a transformative period. Key players will maintain their competitive position through innovation and strategic initiatives. This growth trajectory promises to enhance diagnostic capabilities and improve patient outcomes.

Elevated Prevalence of Chronic Diseases

The C-reactive protein testing market is experiencing a surge in demand due to the escalating prevalence of chronic diseases. In 2022, the highest revenue-generating segment was cardiovascular diseases, which continue to be a leading global health concern. These conditions benefit from CRP testing, as it serves as an established marker for cardiovascular risk assessment. The anticipation of the highest Compound Annual Growth Rate (CAGR) during the forecast period from 2023 to 2031 can be attributed to the increasing incidence of cardiovascular diseases. This trend is substantiated by a study in the European Journal of Preventive Cardiology (2020), which underscores the significant association between elevated high-sensitivity CRP (hs-CRP) levels and an increased risk of cardiovascular events.

Increasing Emphasis on Preventive Healthcare

Preventive medicine has gained substantial traction in recent years, with CRP testing playing a pivotal role. Both conventional CRP and hs-CRP are vital players in this category. Patients and healthcare providers are increasingly adopting CRP tests as part of routine health check-ups and screenings, owing to their cost-effectiveness and ability to detect underlying inflammation. This trend is expected to persist, contributing to the high CAGR projections for conventional CRP and hs-CRP tests from 2023 to 2031.

Technological Advancements in Diagnostics

Continuous advancements in diagnostic technologies are bolstering the accuracy and efficiency of CRP testing. Innovations such as high-sensitivity CRP (hs-CRP) assays offer superior precision in detecting even low levels of inflammation, making them invaluable in various clinical applications. In 2022, hs-CRP tests held a significant share of the market revenue. These technological breakthroughs are projected to continue driving a high CAGR throughout the forecast period.

Regulatory Challenges and Quality Assurance

Despite its growth potential, the C-reactive protein testing market is constrained by regulatory challenges and quality assurance issues. Ensuring consistent accuracy and result quality in CRP testing is a complex endeavor. Laboratories and diagnostic companies must adhere to stringent regulations to uphold test reliability. Any lapses in quality assurance can lead to erroneous diagnoses, with potentially serious consequences for patients. Hence, compliance with regulatory and quality control measures is imperative for sustaining market growth.

Market Segmentation by Detection Range: hs-CRP Tests Dominate the Market

The C-reactive protein testing market is segmented by detection range, and in 2022, hs-CRP tests dominated the market in terms of both revenue and CAGR. The high sensitivity and precision offered by hs-CRP assays have made them the preferred choice for many applications. Conventional CRP tests are also significant contributors in terms of revenue, though with a slightly lower CAGR compared to hs-CRP. cCRP tests, while still relevant, had a comparatively lower share of both revenue and CAGR due to their specialized use.

Market Segmentation by Disease: Cardiovascular Diseases Dominate the Market

The C-reactive protein testing market is further segmented by disease, with cardiovascular diseases accounting for the highest revenue in 2022. However, the highest CAGR from 2023 to 2031 is projected in the cancer segment. This growth is attributed to the increasing use of CRP as a valuable biomarker for cancer diagnosis and monitoring. Additionally, segments related to autoimmune conditions such as rheumatoid arthritis and inflammatory bowel disease are expected to exhibit substantial growth due to the growing adoption of CRP testing for disease management.

North America Remains the Global Leader

In terms of geographic segmentation, the Asia-Pacific region is anticipated to experience the highest CAGR from 2023 to 2031. This can be attributed to the growing healthcare infrastructure, increasing awareness of diagnostic tests, and the rising prevalence of chronic diseases in this region. On the other hand, North America is expected to maintain the highest percentage of market revenue. This is due to its mature healthcare system, widespread adoption of CRP testing, and a high prevalence of cardiovascular diseases in the region.

R&D Development to Enhance Market Share among Key Companies

In 2022, top players in the C-reactive protein testing market included Abbott Laboratories, Siemens Healthineers, Roche Diagnostics., Agilent Technologies, Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Creative Diagnostics, DxGen Corp, CTK Biotech, Inc., Getein Biotech, Inc., Goldsite Diagnostics, Inc., OptiBio Co., Ltd., Nanjing Vazyme Biotech Co., Ltd. These companies are expected to continue their dominance during the forecast period from 2023 to 2031 through product innovation, strategic partnerships, and expanding their geographic presence. They will likely invest in research and development to develop more accurate and efficient CRP testing solutions to maintain their competitive edge.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofC-reactive Protein Testing market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the C-reactive Protein Testing market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Assay Type

  • Immunoturbidimetric Assay
  • ELISA
    • Clinical
    • Non-clinical
  • Chemiluminescence Immunoassay
  • Others

Detection Range

  • hs-CRP
  • Conventional CRP
  • cCRP

Disease Area

  • Cardiovascular Diseases
  • Cancer
  • Rheumatoid Arthritis
  • Inflammatory Bowel Disease
  • Endometriosis
  • Lupus
  • Others

End-Use

  • Clinics
  • By Entity
    • Physician Offices
    • Small Clinics
    • Others
  • By Settings
    • Urban Setting
    • Rural Setting
  • Hospitals
    • Urban Setting
    • Rural Setting
  • Laboratories
    • Urban Setting
    • Rural Setting
  • Assisted Living Healthcare Facilities
    • Urban Setting
    • Rural Setting
  • Home
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of C-reactive Protein Testing market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the C-reactive Protein Testing market?
  • Which is the largest regional market for C-reactive Protein Testing market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving C-reactive Protein Testing market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the C-reactive Protein Testing market worldwide?
Show more
Product Code: 139963-11-23

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global C-reactive Protein Testing Market
  • 2.2. Global C-reactive Protein Testing Market, By Assay Type, 2022 (US$ Million)
  • 2.3. Global C-reactive Protein Testing Market, By Detection Range, 2022 (US$ Million)
  • 2.4. Global C-reactive Protein Testing Market, By Disease Area, 2022 (US$ Million)
  • 2.5. Global C-reactive Protein Testing Market, By End-Use, 2022 (US$ Million)
  • 2.6. Global C-reactive Protein Testing Market, By Geography, 2022 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2022

3. C-reactive Protein Testing Market: Competitive Analysis

  • 3.1. Market Positioning of Key C-reactive Protein Testing Market Vendors
  • 3.2. Strategies Adopted by C-reactive Protein Testing Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. C-reactive Protein Testing Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global C-reactive Protein Testing Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Immunoturbidimetric Assay
    • 5.3.2. ELISA
      • 5.3.2.1. Clinical
      • 5.3.2.2. Non-clinical
    • 5.3.3. Chemiluminescence Immunoassay
    • 5.3.4. Others

6. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. hs-CRP
    • 6.3.2. Conventional CRP
    • 6.3.3. cCRP

7. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Cardiovascular Diseases
    • 7.3.2. Cancer
    • 7.3.3. Rheumatoid Arthritis
    • 7.3.4. Inflammatory Bowel Disease
    • 7.3.5. Endometriosis
    • 7.3.6. Lupus
    • 7.3.7. Others

8. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 8.3. Market Segmentation
    • 8.3.1. Clinics
      • 8.3.1.1. By Entity
        • 8.3.1.1.1. Physician Offices
        • 8.3.1.1.2. Small Clinics
        • 8.3.1.1.3. Others
      • 8.3.1.2. By Settings
        • 8.3.1.2.1. Urban Setting
        • 8.3.1.2.2. Rural Setting
    • 8.3.2. Hospitals
      • 8.3.2.1. Urban Setting
      • 8.3.2.2. Rural Setting
    • 8.3.3. Laboratories
      • 8.3.3.1. Urban Setting
      • 8.3.3.2. Rural Setting
    • 8.3.4. Assisted Living Healthcare Facilities
      • 8.3.4.1. Urban Setting
      • 8.3.4.2. Rural Setting
    • 8.3.5. Home
    • 8.3.6. Others

9. North America C-reactive Protein Testing Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
  • 9.3. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
  • 9.4. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
  • 9.5. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
  • 9.6.C-reactive Protein Testing Market: By Region, 2021-2031, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 9.6.1.1.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 9.6.1.1.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 9.6.1.1.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 9.6.1.2.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 9.6.1.2.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 9.6.1.2.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 9.6.1.3.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 9.6.1.3.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 9.6.1.3.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)

10. UK and European Union C-reactive Protein Testing Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
  • 10.3. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
  • 10.4. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
  • 10.5. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
  • 10.6.C-reactive Protein Testing Market: By Region, 2021-2031, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 10.6.1.1.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 10.6.1.1.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 10.6.1.1.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 10.6.1.2.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 10.6.1.2.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 10.6.1.2.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 10.6.1.3.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 10.6.1.3.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 10.6.1.3.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 10.6.1.4.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 10.6.1.4.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 10.6.1.4.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 10.6.1.5.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 10.6.1.5.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 10.6.1.5.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 10.6.1.6.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 10.6.1.6.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 10.6.1.6.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)

11. Asia Pacific C-reactive Protein Testing Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
  • 11.3. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
  • 11.4. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
  • 11.5. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
  • 11.6.C-reactive Protein Testing Market: By Region, 2021-2031, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 11.6.1.1.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 11.6.1.1.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 11.6.1.1.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 11.6.1.2.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 11.6.1.2.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 11.6.1.2.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 11.6.1.3.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 11.6.1.3.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 11.6.1.3.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 11.6.1.4.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 11.6.1.4.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 11.6.1.4.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 11.6.1.5.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 11.6.1.5.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 11.6.1.5.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 11.6.1.6.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 11.6.1.6.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 11.6.1.6.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)

12. Latin America C-reactive Protein Testing Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
  • 12.3. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
  • 12.4. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
  • 12.5. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
  • 12.6.C-reactive Protein Testing Market: By Region, 2021-2031, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 12.6.1.1.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 12.6.1.1.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 12.6.1.1.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 12.6.1.2.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 12.6.1.2.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 12.6.1.2.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 12.6.1.3.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 12.6.1.3.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 12.6.1.3.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)

13. Middle East and Africa C-reactive Protein Testing Market, 2021-2031, USD (Million)

  • 13.1. Market Overview
  • 13.2. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
  • 13.3. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
  • 13.4. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
  • 13.5. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
  • 13.6.C-reactive Protein Testing Market: By Region, 2021-2031, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 13.6.1.1.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 13.6.1.1.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 13.6.1.1.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 13.6.1.2.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 13.6.1.2.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 13.6.1.2.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. C-reactive Protein Testing Market: By Assay Type, 2021-2031, USD (Million)
        • 13.6.1.3.2. C-reactive Protein Testing Market: By Detection Range, 2021-2031, USD (Million)
        • 13.6.1.3.3. C-reactive Protein Testing Market: By Disease Area, 2021-2031, USD (Million)
        • 13.6.1.3.4. C-reactive Protein Testing Market: By End-Use, 2021-2031, USD (Million)

14. Company Profile

  • 14.1. Abbott Laboratories
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. Siemens Healthineers
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. Roche Diagnostics.
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Agilent Technologies, Inc.
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. Laboratory Corporation of America Holdings
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Thermo Fisher Scientific
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. F. Hoffmann-La Roche Ltd.
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. Creative Diagnostics
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives
  • 14.9. DxGen Corp
    • 14.9.1. Company Overview
    • 14.9.2. Financial Performance
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Initiatives
  • 14.10. CTK Biotech, Inc.
    • 14.10.1. Company Overview
    • 14.10.2. Financial Performance
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Initiatives
  • 14.11. Getein Biotech, Inc.
    • 14.11.1. Company Overview
    • 14.11.2. Financial Performance
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Initiatives
  • 14.12. Goldsite Diagnostics, Inc.
    • 14.12.1. Company Overview
    • 14.12.2. Financial Performance
    • 14.12.3. Product Portfolio
    • 14.12.4. Strategic Initiatives
  • 14.13. OptiBio Co., Ltd.
    • 14.13.1. Company Overview
    • 14.13.2. Financial Performance
    • 14.13.3. Product Portfolio
    • 14.13.4. Strategic Initiatives
  • 14.14. Nanjing Vazyme Biotech Co., Ltd.
    • 14.14.1. Company Overview
    • 14.14.2. Financial Performance
    • 14.14.3. Product Portfolio
    • 14.14.4. Strategic Initiatives
  • 14.15. Other Notable Players
    • 14.15.1. Company Overview
    • 14.15.2. Financial Performance
    • 14.15.3. Product Portfolio
    • 14.15.4. Strategic Initiatives
Show more
Product Code: 139963-11-23

List of Tables

  • TABLE 1 Global C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)
  • TABLE 2 Global C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 3 Global C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 4 Global C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 5 Global C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 6 Global C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 7 Global C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 8 Global C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 9 Global C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 10 Global C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 11 Global C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 12 North America C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 13 North America C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 14 North America C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 15 North America C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 16 North America C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 17 North America C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 18 North America C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 19 North America C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 20 North America C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 21 North America C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 22 North America C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 23 U.S. C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 24 U.S. C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 25 U.S. C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 26 U.S. C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 27 U.S. C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 28 U.S. C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 29 U.S. C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 30 U.S. C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 31 U.S. C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 32 U.S. C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 33 U.S. C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 34 Canada C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 35 Canada C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 36 Canada C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 37 Canada C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 38 Canada C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 39 Canada C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 40 Canada C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 41 Canada C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 42 Canada C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 43 Canada C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 44 Canada C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 45 Rest of North America C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 46 Rest of North America C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 47 Rest of North America C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 48 Rest of North America C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 49 Rest of North America C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 50 Rest of North America C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 51 Rest of North America C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 52 Rest of North America C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 53 Rest of North America C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 54 Rest of North America C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 55 Rest of North America C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 56 UK and European Union C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 57 UK and European Union C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 58 UK and European Union C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 59 UK and European Union C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 60 UK and European Union C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 61 UK and European Union C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 62 UK and European Union C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 63 UK and European Union C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 64 UK and European Union C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 65 UK and European Union C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 66 UK and European Union C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 67 UK C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 68 UK C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 69 UK C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 70 UK C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 71 UK C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 72 UK C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 73 UK C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 74 UK C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 75 UK C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 76 UK C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 77 UK C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 78 Germany C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 79 Germany C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 80 Germany C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 81 Germany C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 82 Germany C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 83 Germany C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 84 Germany C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 85 Germany C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 86 Germany C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 87 Germany C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 88 Germany C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 89 Spain C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 90 Spain C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 91 Spain C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 92 Spain C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 93 Spain C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 94 Spain C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 95 Spain C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 96 Spain C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 97 Spain C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 98 Spain C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 99 Spain C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 100 Italy C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 101 Italy C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 102 Italy C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 103 Italy C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 104 Italy C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 105 Italy C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 106 Italy C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 107 Italy C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 108 Italy C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 109 Italy C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 110 Italy C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 111 France C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 112 France C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 113 France C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 114 France C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 115 France C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 116 France C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 117 France C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 118 France C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 119 France C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 120 France C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 121 France C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 122 Rest of Europe C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 123 Rest of Europe C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 124 Rest of Europe C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 125 Rest of Europe C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 126 Rest of Europe C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 127 Rest of Europe C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 128 Rest of Europe C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 129 Rest of Europe C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 130 Rest of Europe C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 131 Rest of Europe C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 132 Rest of Europe C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 133 Asia C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 134 Asia C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 135 Asia C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 136 Asia C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 137 Asia C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 138 Asia C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 139 Asia C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 140 Asia C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 141 Asia C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 142 Asia C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 143 Asia C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 144 China C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 145 China C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 146 China C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 147 China C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 148 China C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 149 China C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 150 China C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 151 China C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 152 China C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 153 China C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 154 China C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 155 Japan C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 156 Japan C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 157 Japan C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 158 Japan C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 159 Japan C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 160 Japan C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 161 Japan C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 162 Japan C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 163 Japan C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 164 Japan C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 165 Japan C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 166 India C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 167 India C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 168 India C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 169 India C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 170 India C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 171 India C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 172 India C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 173 India C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 174 India C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 175 India C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 176 India C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 177 Australia C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 178 Australia C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 179 Australia C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 180 Australia C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 181 Australia C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 182 Australia C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 183 Australia C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 184 Australia C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 185 Australia C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 186 Australia C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 187 Australia C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 188 South Korea C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 189 South Korea C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 190 South Korea C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 191 South Korea C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 192 South Korea C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 193 South Korea C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 194 South Korea C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 195 South Korea C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 196 South Korea C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 197 South Korea C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 198 South Korea C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 199 Latin America C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 200 Latin America C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 201 Latin America C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 202 Latin America C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 203 Latin America C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 204 Latin America C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 205 Latin America C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 206 Latin America C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 207 Latin America C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 208 Latin America C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 209 Latin America C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 210 Brazil C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 211 Brazil C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 212 Brazil C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 213 Brazil C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 214 Brazil C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 215 Brazil C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 216 Brazil C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 217 Brazil C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 218 Brazil C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 219 Brazil C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 220 Brazil C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 221 Mexico C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 222 Mexico C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 223 Mexico C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 224 Mexico C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 225 Mexico C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 226 Mexico C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 227 Mexico C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 228 Mexico C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 229 Mexico C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 230 Mexico C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 231 Mexico C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 232 Rest of Latin America C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 233 Rest of Latin America C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 234 Rest of Latin America C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 235 Rest of Latin America C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 236 Rest of Latin America C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 237 Rest of Latin America C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 238 Rest of Latin America C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 239 Rest of Latin America C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 240 Rest of Latin America C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 241 Rest of Latin America C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 242 Rest of Latin America C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 243 Middle East and Africa C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 244 Middle East and Africa C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 245 Middle East and Africa C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 246 Middle East and Africa C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 247 Middle East and Africa C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 248 Middle East and Africa C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 249 Middle East and Africa C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 250 Middle East and Africa C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 251 Middle East and Africa C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 252 Middle East and Africa C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 253 Middle East and Africa C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 254 GCC C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 255 GCC C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 256 GCC C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 257 GCC C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 258 GCC C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 259 GCC C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 260 GCC C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 261 GCC C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 262 GCC C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 263 GCC C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 264 GCC C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 265 Africa C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 266 Africa C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 267 Africa C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 268 Africa C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 269 Africa C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 270 Africa C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 271 Africa C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 272 Africa C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 273 Africa C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 274 Africa C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 275 Africa C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

TABLE 276 Rest of Middle East and Africa C-reactive Protein Testing Market By Assay Type, 2021-2031, USD (Million)

  • TABLE 277 Rest of Middle East and Africa C-reactive Protein Testing Market By ELISA, 2021-2031, USD (Million)

TABLE 278 Rest of Middle East and Africa C-reactive Protein Testing Market By Detection Range, 2021-2031, USD (Million)

  • TABLE 279 Rest of Middle East and Africa C-reactive Protein Testing Market By Disease Area, 2021-2031, USD (Million)
  • TABLE 280 Rest of Middle East and Africa C-reactive Protein Testing Market By End-Use, 2021-2031, USD (Million)
  • TABLE 281 Rest of Middle East and Africa C-reactive Protein Testing Market By Clinics, 2021-2031, USD (Million)

TABLE 282 Rest of Middle East and Africa C-reactive Protein Testing Market By By Entity, 2021-2031, USD (Million)

TABLE 283 Rest of Middle East and Africa C-reactive Protein Testing Market By By Settings, 2021-2031, USD (Million)

TABLE 284 Rest of Middle East and Africa C-reactive Protein Testing Market By Hospitals, 2021-2031, USD (Million)

TABLE 285 Rest of Middle East and Africa C-reactive Protein Testing Market By Laboratories, 2021-2031, USD (Million)

TABLE 286 Rest of Middle East and Africa C-reactive Protein Testing Market By Assisted Living Healthcare Facilities, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global C-reactive Protein Testing Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global C-reactive Protein Testing Market: Quality Assurance
  • FIG. 5 Global C-reactive Protein Testing Market, By Assay Type, 2022
  • FIG. 6 Global C-reactive Protein Testing Market, By Detection Range, 2022
  • FIG. 7 Global C-reactive Protein Testing Market, By Disease Area, 2022
  • FIG. 8 Global C-reactive Protein Testing Market, By End-Use, 2022
  • FIG. 9 Global C-reactive Protein Testing Market, By Geography, 2022
  • FIG. 10 Market Geographical Opportunity Matrix - Global C-reactive Protein Testing Market, 2022

FIG. 11Market Positioning of Key C-reactive Protein Testing Market Players, 2022

FIG. 12Global C-reactive Protein Testing Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031

  • FIG. 13 Global C-reactive Protein Testing Market, By Assay Type, 2022 Vs 2031, %
  • FIG. 14 Global C-reactive Protein Testing Market, By Detection Range, 2022 Vs 2031, %
  • FIG. 15 Global C-reactive Protein Testing Market, By Disease Area, 2022 Vs 2031, %
  • FIG. 16 Global C-reactive Protein Testing Market, By End-Use, 2022 Vs 2031, %
  • FIG. 17 U.S. C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 18 Canada C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 19 Rest of North America C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 20 UK C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 21 Germany C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 22 Spain C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 23 Italy C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 24 France C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 25 Rest of Europe C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 26 China C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 27 Japan C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 28 India C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 29 Australia C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 30 South Korea C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 31 Rest of Asia C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 32 Brazil C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 33 Mexico C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 34 Rest of Latin America C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 35 GCC C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 36 Africa C-reactive Protein Testing Market (US$ Million), 2021 - 2031
  • FIG. 37 Rest of Middle East and Africa C-reactive Protein Testing Market (US$ Million), 2021 - 2031
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!